SE0004055D0 - N-type calcium channel antagonists for the treatment of pain - Google Patents

N-type calcium channel antagonists for the treatment of pain

Info

Publication number
SE0004055D0
SE0004055D0 SE0004055A SE0004055A SE0004055D0 SE 0004055 D0 SE0004055 D0 SE 0004055D0 SE 0004055 A SE0004055 A SE 0004055A SE 0004055 A SE0004055 A SE 0004055A SE 0004055 D0 SE0004055 D0 SE 0004055D0
Authority
SE
Sweden
Prior art keywords
sup
treatment
pain
calcium channel
type calcium
Prior art date
Application number
SE0004055A
Other languages
English (en)
Swedish (sv)
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0004055A priority Critical patent/SE0004055D0/xx
Publication of SE0004055D0 publication Critical patent/SE0004055D0/xx
Priority to US10/415,774 priority patent/US6906193B2/en
Priority to JP2002539328A priority patent/JP2004513117A/ja
Priority to EP01981241A priority patent/EP1339689A1/fr
Priority to AU2002212896A priority patent/AU2002212896A1/en
Priority to PCT/SE2001/002390 priority patent/WO2002036568A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
SE0004055A 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain SE0004055D0 (sv)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SE0004055A SE0004055D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain
US10/415,774 US6906193B2 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
JP2002539328A JP2004513117A (ja) 2000-11-06 2001-10-31 疼痛治療のためのｎ−型カルシウムチャンネル拮抗薬
EP01981241A EP1339689A1 (fr) 2000-11-06 2001-10-31 Antagonistes des canaux calciques de type n pour le traitement de la douleur
AU2002212896A AU2002212896A1 (en) 2000-11-06 2001-10-31 N-type calcium channel antagonists for the treatment of pain
PCT/SE2001/002390 WO2002036568A1 (fr) 2000-11-06 2001-10-31 Antagonistes des canaux calciques de type n pour le traitement de la douleur

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004055A SE0004055D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
SE0004055D0 true SE0004055D0 (sv) 2000-11-06

Family

ID=20281715

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0004055A SE0004055D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Country Status (6)

Country Link
US (1) US6906193B2 (fr)
EP (1) EP1339689A1 (fr)
JP (1) JP2004513117A (fr)
AU (1) AU2002212896A1 (fr)
SE (1) SE0004055D0 (fr)
WO (1) WO2002036568A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1541149A1 (fr) * 2002-06-26 2005-06-15 Kyowa Hakko Kogyo Co., Ltd. Inhibiteur de phosphodiesterase
ATE435214T1 (de) * 2004-09-02 2009-07-15 Vertex Pharma Als ionenkanalmodulatoren geeignete chinazoline
WO2009016812A1 (fr) * 2007-07-27 2009-02-05 Kowa Company, Ltd. Agent prophylactique et/ou thérapeutique pour l'anémie comprenant un dérivé de l'acide 2-phénylquinoléine-4-carboxylique comme principe actif

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2009155B (en) * 1977-11-07 1982-07-21 Leo Pharm Prod Ltd Chemical compounds
IT1205640B (it) * 1983-04-06 1989-03-23 Yason Srl Nuovi composti ad attivita' antiinfiammatoria,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
GB9524346D0 (en) * 1995-11-29 1996-01-31 Univ Strathclyde Polycyclic compounds
US5919776A (en) * 1996-12-20 1999-07-06 Merck & Co., Inc. Substituted aminoquinolines as modulators of chemokine receptor activity
US6576644B2 (en) * 2000-09-06 2003-06-10 Bristol-Myers Squibb Co. Quinoline inhibitors of cGMP phosphodiesterase

Also Published As

Publication number Publication date
WO2002036568A1 (fr) 2002-05-10
AU2002212896A1 (en) 2002-05-15
JP2004513117A (ja) 2004-04-30
US6906193B2 (en) 2005-06-14
US20040053964A1 (en) 2004-03-18
EP1339689A1 (fr) 2003-09-03

Similar Documents

Publication Publication Date Title
SE0004053D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9504661D0 (sv) New compounds
NO20026064D0 (no) Nye forbindelser
HK1048990A1 (en) Novel compounds.
DE60334379D1 (de) Copolymerverbindung, diese enthaltende polymerzusammensetzung, bilderzeugungsverfahren und dieselbe benutzende bilderzeugungsvorrichtung
SE0102858D0 (sv) N-type calcium channel antagonists for the treatment of pain
DK0944643T3 (da) Oxyiminopregnancarbolactoner.
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802208D0 (sv) Novel compounds
SE0302139D0 (sv) Novel compounds
EA200001039A1 (ru) Кальцилитические соединения
YU13301A (sh) Muskarinski agonisti i antagonisti
MY133969A (en) Indoloquinazolinones
BR9707247A (pt) Diidrobenzofurano e compostos relacionados úteis como agentes antiinflamatórios
SE0203070D0 (en) Novel compounds
SE0003476D0 (sv) Compounds
SE0203300D0 (sv) Novel Compounds
PL350568A1 (en) N-(2-phenyl-4-aminobutyl)-1-naphtamides as antagonists of neurokinin 1 receptors
SE9802209D0 (sv) Novel compounds
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain
DE60137534D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
SE0102857D0 (sv) N-type calcium channel antagonists for the treatment of pain
CY1106903T1 (el) Φαρμακευτικος συνδυασμος για τη θεραπεια της σπαστικοτητας και/ή του πονου
YU35303A (sh) Preparati n-(1-metiletilaminokarbonil)-4-(3-metilfenil-amino)-3-piridinsulfonamida i cikličnih oligosaharida
UY26498A1 (es) Pirroles sustituidos